Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 15, 2025 • 9:01 AM ET

Date/Time Source News Release
11/08/2022 09:00 AM EST PR Newswire CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma
10/18/2022 09:10 AM EDT PR Newswire CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy
10/13/2022 08:55 AM EDT PR Newswire CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel
09/29/2022 09:10 AM EDT PR Newswire CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate
09/28/2022 09:26 AM EDT PR Newswire CNBX Pharmaceuticals Announces New Patent Granted in Australia
05/05/2022 09:11 AM EDT PR Newswire CNBX Pharmaceuticals Granted Patent in Hong Kong
03/28/2022 09:00 AM EDT PR Newswire Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals
11/04/2021 08:33 AM EDT PR Newswire CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials
10/26/2021 09:15 AM EDT Canada Newswire Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago
10/25/2021 08:55 AM EDT Canada Newswire Radiation Oncology Expert Joins Cannabics Pharmaceuticals' Board of Advisors
Page

Additional News

As of April 15, 2025 • 9:01 AM ET

Date/Time Source News Release
05/10/2024 05:35 AM EDT US Earnings Reports Expected earnings - CNBX Pharmaceuticals Inc
12/29/2022 11:15 AM EST SeekingAlpha Cannabis REITs: Smoked Out
10/13/2022 10:59 AM EDT SeekingAlpha CNBX files patent application for cancer treatment with cannabinoids in US and Israel
05/05/2022 11:25 AM EDT SeekingAlpha CNBX pharma granted patent in Hong Kong for cancer therapy
07/07/2021 09:03 AM EDT SeekingAlpha Cannabics names Inbar Maymon-Pomeranchik as independent board director
05/25/2021 08:55 AM EDT SeekingAlpha Cannabics gets European Patent for personalized medicine drug discovery technology
05/11/2021 08:59 AM EDT SeekingAlpha Cannabics files a PCT patent application for proprietary cancer treatment formulations
05/06/2021 09:35 AM EDT SeekingAlpha Cannabics gets "notice of allowance" from the Mexican Patent and Trademark Office
04/26/2021 09:35 AM EDT SeekingAlpha Cannabics launches research program in melanoma treatment development push
03/17/2021 09:38 AM EDT SeekingAlpha Cannabics' RCC-33 prolongs survival rate in mice inoculated with human colorectal cancer cells
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.